Literature DB >> 12386279

VEGF is an essential molecule for glomerular structuring.

Y Kitamoto1, H Tokunaga, K Miyamoto, K Tomita.   

Abstract

Since glomerular development is regarded as angiogenesis/vasculogenesis, there should be angiogenic cytokines which mediate glomerulogenesis. In the developing kidney, messages of vascular endothelial growth factor (VEGF) and its receptors are expressed in epithelial and endothelial cells of the glomerulus, respectively. In vivo, suppression of VEGF activity by neutralizing antibody seriously interrupts glomerulogenesis. Typically, there are no endothelial cells in the abnormal glomerulus. Structural changes of the glomerulus were clear by observing vascular castings of renal vessels. Although structures of arteries and arterioles were not impaired, the capillary lumen of the glomerulus was completely lost or interrupted halfway through development. It is concluded that VEGF is secreted from the Bowman's capsule, and stimulates endothelial or endothelial progenitor cells in a paracrine fashion to form the glomerulus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386279     DOI: 10.1093/ndt/17.suppl_9.25

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  In vivo maturation of functional renal organoids formed from embryonic cell suspensions.

Authors:  Christodoulos Xinaris; Valentina Benedetti; Paola Rizzo; Mauro Abbate; Daniela Corna; Nadia Azzollini; Sara Conti; Mathieu Unbekandt; Jamie A Davies; Marina Morigi; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2012-10-18       Impact factor: 10.121

2.  Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors.

Authors:  William P Tew; Michael Gordon; John Murren; Jakob Dupont; Sandra Pezzulli; Carol Aghajanian; Paul Sabbatini; David Mendelson; Lawrence Schwartz; Scott Gettinger; Amanda Psyrri; Jesse M Cedarbaum; David R Spriggs
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

Review 3.  Targeted therapies for lung cancer: clinical experience and novel agents.

Authors:  Jill E Larsen; Tina Cascone; David E Gerber; John V Heymach; John D Minna
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

Review 4.  VEGF inhibition, hypertension, and renal toxicity.

Authors:  Suzanne R Hayman; Nelson Leung; Joseph P Grande; Vesna D Garovic
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

5.  Uteroplacental insufficiency affects kidney VEGF expression in a model of IUGR with compensatory glomerular hypertrophy and hypertension.

Authors:  Mariana Baserga; Allyson L Bares; Merica A Hale; Christopher W Callaway; Robert A McKnight; Pascale H Lane; Robert H Lane
Journal:  Early Hum Dev       Date:  2009-02-01       Impact factor: 2.079

6.  Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip.

Authors:  Samira Musah; Akiko Mammoto; Thomas C Ferrante; Sauveur S F Jeanty; Mariko Hirano-Kobayashi; Tadanori Mammoto; Kristen Roberts; Seyoon Chung; Richard Novak; Miles Ingram; Tohid Fatanat-Didar; Sandeep Koshy; James C Weaver; George M Church; Donald E Ingber
Journal:  Nat Biomed Eng       Date:  2017-05-10       Impact factor: 25.671

7.  Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report.

Authors:  Ibrahim Ismail; Sonu Nigam; Alan Parnham; Vinay Srinivasa
Journal:  J Med Case Rep       Date:  2017-08-06

8.  Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis.

Authors:  Joseph Stavas; Guido Filler; Deepak Jain; John Ludlow; Joydeep Basu; Richard Payne; Emily Butler; Maria Díaz-González de Ferris; Tim Bertram
Journal:  Kidney Int Rep       Date:  2022-04-21

9.  Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients.

Authors:  Chie Masaki; Kiminori Sugino; Sakiko Kobayashi; Yoshie Hosoi; Reiko Ono; Haruhiko Yamazaki; Junko Akaishi; Kiyomi Y Hames; Chisato Tomoda; Akifumi Suzuki; Kenichi Matsuzu; Keiko Ohkuwa; Wataru Kitagawa; Mitsuji Nagahama; Koichi Ito
Journal:  BMC Cancer       Date:  2021-08-05       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.